Ekso Bionics Holdings, Inc. Common Stock
NASDAQ:CHRN · NASDAQ Global Market
+$2.44 today
Vol 0.55M · Avg 0.22M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Raj Jegannathan | Chief Technology Officer | — | — | — | — | — |
Lawrence Lam | Chief Product Officer | — | — | — | — | — |
Thomas Jorgensen | Senior Vice President of Marketing | — | — | — | — | — |
Jerome Wong | Chief Financial Officer | — | — | 51 | $64,771.00 | 1.82% |
Ying Cenly Chen | CEO & Director | — | — | — | $0.00 | <0.01% |
Cenly Chen | Chief Executive Officer | — | — | — | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Peer companies in the same sector
No competitor data available.
Who manages CHRN?
Ekso Bionics Holdings, Inc. Common Stock (CHRN) lists 6 active executives. The top listed executive is Raj Jegannathan, Chief Technology Officer.
Are CHRN insiders buying or selling?
Recent insider activity shows net buying of $0.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.